Xortx Therapeutics INC. (XRTX) — 6-K Filings

All 6-K filings from Xortx Therapeutics INC.. Browse 49 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (49)

XORTX Therapeutics Files 6-K Report — Apr 21, 2026 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on April 21, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The
6-K Filing — Apr 1, 2026
XORTX Therapeutics Files 6-K Report — Mar 27, 2026 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on March 27, 2026, reporting information as of March 26, 2026. The filing includes a press release as an exhibit.
6-K Filing — Mar 27, 2026
XORTX Therapeutics Files Q3 2025 Financial Report — Nov 17, 2025 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on November 17, 2025, reporting its financial results for the period ending September 30, 2025. The filing includes con
XORTX Therapeutics Files October 2025 6-K Report — Oct 31, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 31, 2025, reporting for the month of October 2025. The filing incorporates by reference Exhibits 99.2 and 99
XORTX Therapeutics Files October 2025 Report — Oct 29, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 29, 2025, to report its activities for the month of October 2025. The filing indicates that the company is a
XORTX Therapeutics Files 6-K, Incorporates Exhibits — Oct 23, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 23, 2025, reporting for the month of October 2025. The filing incorporates by reference Exhibits 99.2, 99.3,
XORTX Therapeutics Files October 2025 6-K Report — Oct 21, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 21, 2025, reporting for the month of October 2025. The filing was signed by CEO Allen Davidoff on October 20
XORTX Therapeutics Files October 2025 Report — Oct 17, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 17, 2025, to report its activities for the month of October 2025. The filing indicates that the company is a
XORTX Therapeutics Files September 2025 6-K Report — Sep 4, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on September 4, 2025, to report for the month of September 2025. The filing indicates that the company is a foreign pri
XORTX Therapeutics Files September 2025 6-K Report — Sep 3, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on September 3, 2025, to report its activities for the month of September 2025. The filing indicates that the company i
XORTX Therapeutics Files 6-K with Financials — Aug 15, 2025 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on August 15, 2025, reporting for the period ending June 30, 2025. The filing includes condensed interim consolidated f
XORTX Therapeutics Files August 2025 6-K Report — Aug 7, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on August 7, 2025, to report for the month of August 2025. The filing indicates the company is a foreign private issuer
XORTX Therapeutics Files June 2025 6-K Report — Jun 26, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on June 26, 2025, reporting for the month of June 2025. The filing indicates the company is a foreign private issuer an
XORTX Therapeutics Files May 2025 6-K Report — May 19, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on May 19, 2025, to report its activities for the month of May 2025. The filing indicates that the company is a foreign
XORTX Therapeutics Files Q1 2025 Financial Report — May 16, 2025 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on May 16, 2025, reporting its financial results for the three months ended March 31, 2025. The filing includes condens
XORTX Therapeutics Files April 2025 6-K Report — Apr 30, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on April 30, 2025, reporting for the month of April 2025. The filing indicates that the company is a foreign private is
XORTX Therapeutics Files April 2025 6-K Report — Apr 28, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on April 28, 2025, reporting for the month of April 2025. The filing indicates that the company is a foreign private is
XORTX Therapeutics Files April 2025 6-K Report — Apr 18, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on April 18, 2025, reporting for the month of April 2025. The filing indicates the company is a foreign private issuer
XORTX Therapeutics Files March 2025 6-K with Annual Info — Apr 1, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on April 1, 2025, reporting for the month of March 2025. The filing includes their Annual Information Form for the year
XORTX Therapeutics Files 2024 Financials and MD&A — Mar 26, 2025 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on March 26, 2025, reporting its consolidated financial statements for the years ended December 31, 2024, 2023, and 202
XORTX Therapeutics Files March 2025 6-K Report — Mar 19, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on March 19, 2025, to report its activities for the month of March 2025. The filing indicates that the company is a for
XORTX Therapeutics Files February 2025 6-K Report — Feb 24, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on February 24, 2025, to report for the month of February 2025. The filing indicates that the company is a foreign priv
XORTX Therapeutics Files January 2025 Report — Jan 29, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on January 29, 2025, to report its activities for the month of January 2025. The filing indicates the company is a fore
XORTX Therapeutics Changes Auditor — Jan 22, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on January 22, 2025, to report a change in its auditor. The company has appointed Smythe LLP as its new auditor, replac
XORTX Therapeutics Files January 2025 6-K Report — Jan 21, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on January 21, 2025, reporting for the month of January 2025. The filing was signed by CEO Allen Davidoff on January 17
XORTX Therapeutics Files January 2025 6-K Report — Jan 6, 2025 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on January 6, 2025, to report for the month of January 2025. The filing indicates that the company is a foreign private
XORTX Therapeutics Inc. Files December 2024 Report — Dec 19, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on December 19, 2024, to report its activities for the month of December 2024. The company, headquartered in Calgary, A
XORTX Therapeutics Files December 2024 Report — Dec 12, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on December 12, 2024, to report its activities for the month of December 2024. The filing indicates that the company is
XORTX Therapeutics Files Q3 2024 Financial Report — Nov 15, 2024 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on November 15, 2024, reporting its financial results for the nine months ended September 30, 2024. The filing includes
XORTX Therapeutics Files October 2024 6-K Report — Oct 24, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 24, 2024, to report its activities for the month of October 2024. The filing indicates that the company is a
XORTX Therapeutics Files October 2024 6-K Report — Oct 18, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 18, 2024, to report its activities for the month of October 2024. The filing indicates that the company is a
XORTX Therapeutics Files 6-K, Incorporates Exhibits — Oct 18, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 18, 2024, incorporating by reference Exhibits 5.1 and 5.2 into its existing Form F-3 Registration Statement
XORTX Therapeutics Files October 2024 Report — Oct 17, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 17, 2024, to report its activities for the month of October 2024. The filing indicates that the company is a
XORTX Therapeutics Files October 2024 Report — Oct 9, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on October 9, 2024, to report its activities for the month of October 2024. The filing indicates the company is a forei
XORTX Therapeutics Files 6-K Report — Sep 13, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on September 13, 2024. The report indicates the company is a foreign private issuer and will file its annual reports un
XORTX Therapeutics Files September 2024 6-K Report — Sep 6, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on September 6, 2024, reporting for the month of September 2024. The company, incorporated in Alberta, Canada, is invol
XORTX Therapeutics Files September 2024 Report — Sep 4, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on September 3, 2024, to report its activities for the month of September 2024. The filing indicates that the company i
XORTX Therapeutics Files August 2024 Report — Aug 29, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on August 29, 2024, to report its activities for the month of August 2024. The filing indicates that the company is a f
XORTX Therapeutics Files August 2024 Report — Aug 23, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on August 23, 2024, to report its activities for the month of August 2024. The filing indicates that the company is a f
XORTX Therapeutics Files August 2024 Report — Aug 22, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on August 22, 2024, reporting for the month of August 2024. The filing includes notices and information circulars relat
XORTX Therapeutics Files August 2024 Report — Aug 20, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on August 20, 2024, to report its activities for the month of August 2024. The filing indicates that the company is a f
XORTX Therapeutics Files 6-K with Q2 2024 Financials — Aug 15, 2024 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on August 15, 2024, reporting its financial results for the period ending June 30, 2024. The filing includes condensed
XORTX Therapeutics Files June 2024 6-K with Executive Compensation Data — Jul 1, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on June 28, 2024, reporting for the month of June 2024. The filing includes Exhibit 99.1, which is a Statement of Execu
XORTX Therapeutics Files June 2024 Report (6-K) — Jun 12, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on June 12, 2024, to report its activities for the month of June 2024. The filing indicates that the company is a forei
XORTX Therapeutics Files June 2024 Report — Jun 4, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on June 4, 2024, to report its activities for the month of June 2024. The filing indicates that the company is a foreig
XORTX Therapeutics Files 6-K Report — May 20, 2024 Risk: low
XORTX Therapeutics Inc. filed a Form 6-K on May 17, 2024, to report its activities for the month of May 2024. The filing confirms that the company is a foreign
XORTX Therapeutics Files Q1 2024 Financial Results — May 17, 2024 Risk: medium
XORTX Therapeutics Inc. filed a Form 6-K on May 17, 2024, reporting its financial results for the three months ended March 31, 2024. The filing includes condens

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX